These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31158331)

  • 41. The molecular pathogenesis of the Philadelphia-positive leukemias: implications for diagnosis and therapy.
    Van Etten RA
    Cancer Treat Res; 1993; 64():295-325. PubMed ID: 8095796
    [No Abstract]   [Full Text] [Related]  

  • 42. The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.
    Jeon EK; Lim J; Kim M; Yahng SA; Lee SE; Cho BS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lee S
    Leukemia; 2011 Feb; 25(2):366-7. PubMed ID: 21072049
    [No Abstract]   [Full Text] [Related]  

  • 43. Monitoring of childhood ALL using
    Hovorkova L; Zaliova M; Venn NC; Bleckmann K; Trkova M; Potuckova E; Vaskova M; Linhartova J; Machova Polakova K; Fronkova E; Muskovic W; Giles JE; Shaw PJ; Cario G; Sutton R; Stary J; Trka J; Zuna J
    Blood; 2017 May; 129(20):2771-2781. PubMed ID: 28331056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
    Ottmann OG; Pfeifer H
    Hematology Am Soc Hematol Educ Program; 2009; ():371-81. PubMed ID: 20008223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Allogeneic transplantation for patients with Philadelphia chromosome positive acute lymphoblastic leukemia: Is it imperative in the tyrosine kinase inhibitor era?
    Litzow MR
    Best Pract Res Clin Haematol; 2018 Dec; 31(4):357-360. PubMed ID: 30466747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cytogenetic and prognostic analysis in adult patients with Philadelphia chromosome-positive and bcr-abl positive acute lymphoblastic leukaemia].
    Li YN; Zou DH; Gu M; Zhao YZ; Qi JY; Mi YC; Wang JX; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):298-302. PubMed ID: 19799123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of adult Ph-negative acute lymphoblastic leukemia].
    Imai K
    Rinsho Ketsueki; 2014 Oct; 55(10):1962-71. PubMed ID: 25297761
    [No Abstract]   [Full Text] [Related]  

  • 48. Genotype-phenotype correlation of unusual BCR-ABL1 transcripts in Philadelphia chromosome-positive leukaemia.
    Gong Z; Zhou T; Liu H; Tang G; Yin CC; Wang W; Medeiros LJ; Hu S
    Br J Haematol; 2020 Jun; 189(5):e207-e211. PubMed ID: 32237084
    [No Abstract]   [Full Text] [Related]  

  • 49. PCR-detectable transcripts in long-term remission of P190(BCR/ABL)-positive acute lymphoblastic leukemia.
    Annino L; Ferrari A; Lamanda M; Mandelli F; Lo Coco F; Pane F
    Blood; 2000 Jun; 95(12):4018-9. PubMed ID: 10939799
    [No Abstract]   [Full Text] [Related]  

  • 50. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
    Drexler HG; MacLeod RA; Uphoff CC
    Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lestingi TM; Hooberman AL
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):161-75. PubMed ID: 8449857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tyrosine kinase inhibitors in BCR-ABL positive acute lymphoblastic leukemia.
    Leoni V; Biondi A
    Haematologica; 2015 Mar; 100(3):295-9. PubMed ID: 25740105
    [No Abstract]   [Full Text] [Related]  

  • 53. Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.
    Stirewalt DL; Guthrie KA; Beppu L; Bryant EM; Doney K; Gooley T; Appelbaum FR; Radich JP
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):206-12. PubMed ID: 12652472
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rituximab can be useful as treatment for minimal residual disease in bcr-abl-positive acute lymphoblastic leukemia.
    Jándula BM; Nomdedeu J; Marín P; Vivancos P
    Bone Marrow Transplant; 2001 Jan; 27(2):225-7. PubMed ID: 11281397
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
    De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
    BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence.
    Bleckmann K; Schrappe M
    Br J Haematol; 2016 Mar; 172(6):855-69. PubMed ID: 26773444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of the BCR-ABL gene by reverse transcription/polymerase chain reaction and fluorescence in situ hybridization in a patient with Philadelphia chromosome negative acute lymphoblastic leukaemia.
    van Rhee F; Kasprzyk A; Jamil A; Dickinson H; Lin F; Cross NC; Galvin MC; Goldman JM; Secker-Walker LM
    Br J Haematol; 1995 May; 90(1):225-8. PubMed ID: 7786793
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.
    Hatta Y; Mizuta S; Matsuo K; Ohtake S; Iwanaga M; Sugiura I; Doki N; Kanamori H; Ueda Y; Yoshida C; Dobashi N; Maeda T; Yujiri T; Monma F; Ito Y; Hayakawa F; Takeuchi J; Kiyoi H; Miyazaki Y; Naoe T
    Ann Hematol; 2018 Sep; 97(9):1535-1545. PubMed ID: 29694642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
    Rambaldi A; Attuati V; Bassan R; Neonato MG; Viero P; Battista R; Di Bona E; Rossi G; Pogliani E; Ruggeri M; Amaru R; Rivolta A; Giudici G; Biondi A; Barbui T
    Leuk Lymphoma; 1996 May; 21(5-6):457-66. PubMed ID: 9172811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SOHO State of the Art Updates & Next Questions: Intensive and Non-Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
    Short NJ; Kantarjian H; Jabbour E
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):61-66. PubMed ID: 34561201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.